All news articles
Thursday 23 June 2016 Research
Scientists at Queen Mary University of London have made a discovery which could help with the development of...
Thursday 16 June 2016 General
The National Institute for Health and Care Excellence (NICE) has published an update to their quality standard for...
Monday 13 June 2016 Research
Scientists part-funded by Breast Cancer Now have discovered how a new class of drug – known as BET inhibitors –...
Response to trial showing ‘significant potential’ of first-in-class drug palbociclib, amid concern it won’t be made available in UK
Tuesday 7 June 2016 General
New research presented to the American Society of Clinical Oncology (ASCO) has demonstrated the ‘significant...
Monday 6 June 2016 Scotland
The Breast Cancer Now Ladies Day at Perth Racecourse has raised more than £12,500 from their annual event on 12 May...
Response to new research suggesting that extending aromatase inhibitor treatment could help prevent disease returning
Monday 6 June 2016 Research
In a new trial presented to the American Society of Clinical Oncology (ASCO) in Chicago this weekend, scientists...
Cholesterol production could drive resistance to anti-hormone treatment in patients with ER+ breast cancer
Wednesday 1 June 2016 Research
Breast Cancer Now-funded Scientists discover why some of the most commonly used breast cancer treatments...
Breast Cancer Now responds to NICE draft guidance rejecting neoadjuvant Perjeta to treat early HER2+ breast cancer
Friday 20 May 2016 General
Our CEO, Baroness Delyth Morgan, comments on draft guidelines issued today by NICE recommending pertuzumab (...
Tuesday 17 May 2016 Scotland
Our Policy and Campaigns Manager in Scotland, Lawrence Cowan, comments on the latest statistics published today....
Monday 16 May 2016 Campaigns and policy
Experts warn that without wider NICE reform, many effective cancer medicines will not be available to patients in...